U.S. Sen. Baldwin: Ahead of Trump’s prescription drug pricing speech, Baldwin presses Trump administration on holding pharmaceutical companies accountable for price hikes

Contact: press@baldwin.senate.gov, 202-224-6225 WASHINGTON, D.C. – On the eve of the President’s speech to roll out his plan to address skyrocketing prescription drug prices, U.S. Senator Tammy Baldwin, a member of the Senate Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies,